Nurse/HCA SOPs
- Uncategorized
-
PGD'S
-
Dukoral_-PGD
-
C1619-patient-group-direction-for-spikevax-31-march
-
C1617-patient-group-direction-for-comirnaty-10-micrograms-dose-COVID-19-mRNA-vaccine
-
C1617-patient-group-direction-for-comirnaty-10-micrograms-dose-COVID-19-mRNA-vaccine
-
C1618-patient-group-direction-for-comirnaty-30-micrograms-dose-31-march.pdf-v1.1
-
Inactivated-Influenza-
-
Fluenz-Tetra-
-
C1685-pgd-spikevax-original-omicron-covid-19-vaccine-v1.01
-
Bexsero
-
Bexsero-Risk-Groups23-1
-
Boostrix-IPV-Repevax
-
Engerix-B-HBvaxPRO
-
Fendrix-HBvaxPRO-Engerix-B
-
Gardasil-Gardasil-9
-
Gardasil-Gardasil-9-MSM
-
Hepatitis-A-inactivated-vaccine-
-
Infanrix-hexa-Vaxelis-
-
Menitorix
-
MenveoNimenrixMedQuadfi-for-Risk-Groups-1
-
Menveo-Nimenrix-MenQuadfi
-
MMRVaxPRO-Priorix
-
Pneumovax-23-PPV23
-
Prevenar13-
-
Repevax-Boostrix-IPV
-
Revaxis
-
Rotarix-
-
Shingrix
-
Twinrix-Adult-Twinrix-Paediatric-Ambirix
-
TYPHIM-Vi-
-
ViATIM-
-
Zostavax
-
-
Protocols
-
599 - Lower Limb Treatment CPG Pathway V2.1 final version
-
best-practice-statement-addressing-complexities-management-venous-leg-ulcers
-
Needle stick/fluids exposure protocol
-
Urinary Symptoms in Pregnancy Pathway (2)
-
Sexual abuse pathway with guidance Dec 2021 FINAL
-
V2.0 Usage of Gloves
-
V2.0 Infection Control Outbreak Incident Guidance
-
wound care sop
-
travel vaccination sop
-
- CDM protocols
- Care home/in patient protocols
- General
C1617-patient-group-direction-for-comirnaty-10-micrograms-dose-COVID-19-mRNA-vaccine
| Views | |
|---|---|
| 6 | Total Views |
| 6 | Members Views |
| 0 | Public Views |
| Actions | |
|---|---|
| 0 | Likes |
| 0 | Dislikes |
| 0 | Comments |
Share by mail
Please login to share this document by email.
Embed in your website
Select page to start with